Tyche Wealth Partners’s Bristol-Myers Squibb BMY Stock Holding History

Tyche Wealth Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$232K	Buy	3,817 +5	+0.1%	+$291	0.04%	314
2025 Q4	$206K	Buy	+3,812	New	+$183K	0.03%	313
2025 Q3	–	Sell	-5,618	Closed	-$260K	–	320
2025 Q2	$260K	Sell	5,618 -703	-11%	-$34.5K	0.05%	238
2025 Q1	$386K	Buy	6,321 +592	+10%	+$34.5K	0.08%	165
2024 Q4	$324K	Buy	5,729 +979	+21%	+$54.7K	0.07%	206
2024 Q3	$246K	Sell	4,750 -991	-17%	-$46.5K	0.06%	236
2024 Q2	$238K	Sell	5,741 -902	-14%	-$40.4K	0.06%	227
2024 Q1	$360K	Sell	6,643 -154	-2%	-$7.84K	0.09%	176
2023 Q4	$349K	Buy	+6,797	New	+$357K	0.08%	202

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tyche Wealth Partners's BMY Position: Q1 2026 in Review

Tyche Wealth Partners increased its Bristol-Myers Squibb (BMY) stake by 0.13% in Q1 2026, buying an estimated $291 and bringing the position to 3,817 shares worth $232K. The position accounts for 0.04% of the portfolio, ranked #314.

Tyche Wealth Partners first reported a position in BMY in Q4 2023 and has held it in 9 quarters since. The position peaked at $386K in Q1 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Tyche Wealth Partners held 3,817 shares of Bristol-Myers Squibb worth $232K as of Q1 2026.
Tyche Wealth Partners bought 5 Bristol-Myers Squibb shares in Q1 2026, an estimated $291.
Bristol-Myers Squibb made up 0.04% of Tyche Wealth Partners's portfolio in Q1 2026, its #314 holding.
Tyche Wealth Partners first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 9 quarters since.
Tyche Wealth Partners's Bristol-Myers Squibb position peaked at $386K in Q1 2025.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Tyche Wealth Partners's 13F filing for Q1 2026, filed 6 May 2026.